Analyst price target range
4D Molecular Therapeutics Price Target: $29.10 Average
FDMT target range is $18.00 to $37.00. As of 2026-08-31.
Direct answer
4D Molecular Therapeutics's average price target is $29.10.
The verified analyst range runs from $18.00 to $37.00.
The low target implies +22.7%, the high target implies +152.2%, and the range spans 129.5% of the current price.
Forecast evidence checked August 31, 2026.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.67
- Average price target
- $29.10
- High price target
- $37.00
- Low price target
- $18.00
- Low target gap
- +22.7%
- Target upside
- +98.4%
- High target gap
- +152.2%
- Target range width
- 129.5%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is 4D Molecular Therapeutics's average price target?
4D Molecular Therapeutics's verified average price target is $29.10. The target range is $18.00 to $37.00.
How far are 4D Molecular Therapeutics's low and high targets from the recorded price?
The low target implies +22.7%, while the high target implies +152.2%.
How many analysts are included in 4D Molecular Therapeutics's consensus?
The verified consensus includes 10 analysts.
How is 4D Molecular Therapeutics's target upside or downside calculated?
The average target of $29.10 is divided by the recorded price of $14.67, then one is subtracted to produce +98.4%. This does not guarantee a future return.
When was 4D Molecular Therapeutics's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.